Objectives: To describe allergic asthma and allergic rhinitis pathophysiology and review the pharmacologic, pharmacokinetic, pharmacodynamic, efficacy, and safety data for omalizumab. Methods ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback